Sera Prognostics Inc (SERA) support and resistance · rev $77.0K
Sera Prognostics Inc (SERA) is a medical devices company listed on US.
This page maps Sera Prognostics Inc (SERA) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported SERA revenue for 2024-12-31 was $77.0K. Net income was -$32.9M. Revenue was down 74.8% from 2023-12-31 to 2024-12-31. SERA currently screens at market cap $89.1M.
SERA currently screens at market cap $89.1M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new SERA 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the SERA quote page for the session range and the stock page for the full model.
Not investment advice.